Pnacreatic cancer Liver cancer pancreatic cancer, liver cancer
Conditions
Interventions
Adaptive proton therapy
D046650
Sponsors
Uchinami Yusuke
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who are 20 years of age or older at the time of obtaining consent ECOG performance status is 0 Patients with pathologically confirmed malignancy or clinically diagnosed malignancy No evidence of distant metastasis Judged to be appropriate for proton therapy by multidisciplinary tumor board
Exclusion criteria
Exclusion criteria: In patients with pacreatic cancer, previous treatment of radiotherapy or surgery Pregnant women or those who are breastfeeding Judged by the principal investigator to be inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of replanning during proton therapy based on the planning CT images | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of adverse events occurring up to 6 months post-treatment Number of times tumor dose constraint could not be achieved at the mid-treatment evaluation CT Number of times gastrointestinal dose constraints were not achieved at mid-treatment evaluation CT | — |
Contacts
Public ContactYusuke Uchinami
Department of Radiation Oncology, Hokkaido University Faculty of Medicine and Graduate School of Medicine
Outcome results
None listed